Downregulation of LPR1 at the blood–brain barrier in streptozotocin-induced diabetic mice
Deposition of amyloid-β peptide (Aβ) in the diabetic brain is poorly understood. Low-density lipoprotein receptor related protein 1(LRP1) at the blood–brain barrier (BBB) is critical for regulation of Aβ homeostasis in the brain. In this study, we used streptozotocin-induced diabetic mice to observe...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 2009-05, Vol.56 (6), p.1054-1059 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Deposition of amyloid-β peptide (Aβ) in the diabetic brain is poorly understood. Low-density lipoprotein receptor related protein 1(LRP1) at the blood–brain barrier (BBB) is critical for regulation of Aβ homeostasis in the brain. In this study, we used streptozotocin-induced diabetic mice to observe the expression of LRP1 at the BBB by Western blot and immunocytochemical analysis, and to study in vivo brain-to-blood efflux transport of
125I-Aβ1–40 using brain clearance studies. In the diabetic mice with hyperglycemia (>16.0
mmol/l) at 6
weeks, LRP1 expression at the BBB was significantly downregulated; no significant changes of LRP1 levels were found at 1 and 3
weeks after diabetes induction. The data of brain clearance studies for Aβ showed significant decrease in LRP1-dependent transport of Aβ across the BBB at 6
weeks after diabetes induction, while no significant changes of LRP1-dependent transport of Aβ across the BBB at 1 or 3
weeks after diabetes induction were apparent. We conclude that the downregulation of LRP1 at the BBB contributes to cerebral Aβ deposition in diabetes mellitus. |
---|---|
ISSN: | 0028-3908 1873-7064 |
DOI: | 10.1016/j.neuropharm.2009.03.001 |